Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
By Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 158
Description
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology.
Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com.
Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.
Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com.
Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.
| Episode | Date |
|---|---|
|
FDA Approves Semaglutide (Wegovy) for MASH
|
Aug 22, 2025 |
|
ADCES 2025 Part 3 & Diabetes Tech Updates
|
Aug 22, 2025 |
|
ADCES 2025 Recap Part 2
|
Aug 22, 2025 |
|
Orforglipron Topline Results & ADCES 2025 Part 1
|
Aug 19, 2025 |
|
Tirzepatide and SURPASS-CVOT Topline Results
|
Aug 05, 2025 |
|
Guideline Updates for Diabetes & Pregnancy
|
Jul 23, 2025 |
|
GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025
|
Jul 21, 2025 |
|
Upcoming Research on Type 1 Diabetes in Pregnancy with Carol Levy, MD
|
Jul 18, 2025 |
|
BELIEVE, GLP-1/GIP Agonists, and CATALYST Results at ADA 2025
|
Jul 16, 2025 |
|
American Diabetes Association 2025 Trial Recap - Part 1
|
Jul 16, 2025 |
|
The Diabetes Collective, with Rachael Sood, RN, MSN, APRN
|
Jun 24, 2025 |
|
Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD
|
Jun 24, 2025 |
|
CATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhD
|
Jun 23, 2025 |
|
Updates from Dexcom at ADA 2025, with Kevin Sayer
|
Jun 22, 2025 |
|
REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
|
Jun 22, 2025 |
|
ADA 2025 Preview
|
Jun 11, 2025 |
|
American Diabetes Association Consensus Report on MASLD
|
Jun 04, 2025 |
|
May 2025 Diabetes Tech & Breakthrough T1D Updates
|
Jun 02, 2025 |
|
INHALE-3 Trial and Afrezza, With Roy Beck, MD, PhD
|
May 28, 2025 |
|
Diabetes Dialogue: AACE 2025 Recap
|
May 26, 2025 |
|
Real-World Impact of iLet Bionic Pancreas, With Steven Russell, MD, PhD
|
May 20, 2025 |
|
Luna Automated Insulin Delivery, With Jon Brilliant and John Sjölund
|
May 13, 2025 |
|
Tirzepatide vs Semaglutide for Obesity, Understanding SURMOUNT-5
|
May 11, 2025 |
|
Diabetes Dialogue: Dexcom G7, Libre App, and Medtronic Simplera Sync
|
May 07, 2025 |
|
Diabetes Dialogue: Semaglutide for MASH in ESSENCE Trial, With Arun Sanyal, MD
|
Apr 30, 2025 |
|
Diabetes Dialogue: CATALYST Reveals High Prevalence of Hypercortisolism in T2D
|
Apr 29, 2025 |
|
Diabetes Dialogue: Oral GLP-1 Orforglipron in ACHIEVE-1 Trial
|
Apr 24, 2025 |
|
Diabetes Dialogue: Screening for Presymptomatic T1D with Rifka Schulman-Rosenbaum, MD
|
Apr 15, 2025 |
|
Diabetes Dialogue: SOUL and STRIDE Trials from ACC 2025
|
Apr 09, 2025 |
|
Diabetes Dialogue: Updates and News from ATTD 2025 Part 1
|
Apr 04, 2025 |
|
Diabetes Dialogue: Understanding Control-IQ+ AID Algorithm with Laurel Messer, PhD, RN
|
Mar 18, 2025 |
|
Omnipod 5 and Medtronic 780G for Type 2 Diabetes
|
Feb 15, 2025 |
|
ADA’s 2025 Standards of Care in Diabetes Therapeutics
|
Jan 23, 2025 |
|
ADA’s 2025 Standards of Care in Diabetes Technology
|
Jan 16, 2025 |
|
The Evolving Role of Registered Dietitian Nutritionists in Obesity
|
Jan 13, 2025 |
|
Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas
|
Jan 06, 2025 |
|
Insights on INHALE-1 and CATALYST Trials
|
Jan 02, 2025 |
|
Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss
|
Dec 22, 2024 |
|
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor
|
Dec 16, 2024 |
|
Celebrating 25 Years of CGM, with Irl Hirsch, MD
|
Dec 15, 2024 |
|
News and Updates in Diabetes at AHA 2024
|
Nov 21, 2024 |
|
Tirzepatide’s Long-Term Obesity Data
|
Nov 14, 2024 |
|
Latest Updates on Semaglutide
|
Nov 14, 2024 |
|
Diabetes Tech Updates in October 2024
|
Nov 11, 2024 |
|
What to Know About the Eversense 365 CGM, with Brian Hansen
|
Oct 16, 2024 |
|
Lingo Availability & Embecta's Tubeless Patch Pump
|
Sep 11, 2024 |
|
Real-World Experience with Dexcom Stelo
|
Sep 11, 2024 |
|
Sotagliflozin for T1D and Other ADCES Highlights
|
Aug 21, 2024 |
|
First 10 Prices Announced from CMS Price Negotiations
|
Aug 19, 2024 |
|
Navigating ADCES 2024
|
Aug 19, 2024 |
|
SUMMIT and FINEARTS-HF, with Muthiah Vaduganathan, MD, MPH
|
Aug 10, 2024 |
|
Simplera CGM and Medtronic's Partnership with Abbott
|
Aug 10, 2024 |
|
CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD
|
Aug 02, 2024 |
|
New Early-Stage T1D Monitoring Guidance, with Anastasia Albanese-O'Neill, PhD, APRN
|
Jul 18, 2024 |
|
INHALE-3 and Diabetes Tech Updates, with Grazia Aleppo, MD
|
Jul 18, 2024 |
|
Blue Circle Health, with Monica Gomberg, MD
|
Jul 18, 2024 |
|
Advances in AID and CGM at ADA 2024, with Davida Kruger, NP
|
Jul 18, 2024 |
|
ADA Introduces Obesity Association, with Robert Gabbay, MD, PhD
|
Jul 18, 2024 |
|
Patient Considerations for Inhaled Insulin, with Carol Levy, MD
|
Jul 18, 2024 |
|
ADA 2024 Diabetes Technology Recap
|
Jul 18, 2024 |
|
June 2024 Updates in Diabetes Technology and T1D
|
Jun 17, 2024 |
|
GLAM and CRISTAL, Updates in Pregnancy
|
Jun 05, 2024 |
|
FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease
|
May 31, 2024 |
|
2024 ACP Type 2 Diabetes Recommendations
|
Apr 20, 2024 |
|
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
|
Apr 20, 2024 |
|
What to Know about Sequel Med Tech's twiist AID System, with Alan Lotvin, MD
|
Mar 30, 2024 |
|
Hot Topics and Updates from ATTD 2024
|
Mar 30, 2024 |
|
T1D Glycemic Improvement and CRISTAL at ATTD 2024
|
Mar 26, 2024 |
|
FLOW Trial and Chronic Kidney Disease Updates, with Brendon Neuen, MBBS, PhD
|
Mar 22, 2024 |
|
Dexcom Stelo and CGM Updates, with Jake Leach
|
Mar 22, 2024 |
|
Tirzepatide and the Future of Incretin Therapies, with Timothy Garvey, MD
|
Mar 18, 2024 |
|
SELECT, Semaglutide, & the Future of Incretin Therapies, with A. Michael Lincoff, MD
|
Mar 02, 2024 |
|
Understanding MARD, Comparing Popular CGM Sensors
|
Feb 29, 2024 |
|
ATTD 2024 Preview
|
Feb 26, 2024 |
|
Time in Range, CGM Metrics for Predicting Outcomes in Diabetes
|
Feb 20, 2024 |
|
Tirzepatide in Type 1 Diabetes, with Viral Shah, MD
|
Feb 15, 2024 |
|
Diabetes Technology Updates in January 2024
|
Jan 10, 2024 |
|
Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD
|
Jan 09, 2024 |
|
Latest Updates on Diabetes Management in Pregnancy
|
Jan 08, 2024 |
|
Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes
|
Jan 03, 2024 |
|
Diabetes Dialogue: 2023 Top Episodes Recap
|
Jan 01, 2024 |
|
Key Updates in ADA Standards of Care—2024
|
Dec 29, 2023 |
|
Diabetes Technology Updates and Standards of Care—2024
|
Dec 19, 2023 |
|
SELECT Proves Semaglutide 2.4 mg CV Benefit at AHA 2023
|
Nov 11, 2023 |
|
Tirzepatide (Zepbound) Approved for Chronic Weight Management
|
Nov 08, 2023 |
|
Diabetes Dialogue: Automated Insulin Delivery News in October 2023
|
Nov 01, 2023 |
|
SURMOUNT-3 and SURMOUNT-4 Data
|
Oct 27, 2023 |
|
PROTECT Data and Teplizumab in Newly Diagnosed T1D
|
Oct 25, 2023 |
|
Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical
|
Sep 19, 2023 |
|
Making Sense of Semaglutide in Type 1 Diabetes
|
Sep 08, 2023 |
|
Clearance of Tandem Mobi and Welldoc's BlueStar Platform
|
Sep 02, 2023 |
|
Addressing Health Disparities with Diabetes Technology, with Etty Vider, PharmD
|
Sep 02, 2023 |
|
What Medicare Drug Price Negotiations Mean for Diabetes
|
Aug 29, 2023 |
|
Diabetes Dialogue: The Role of Nutrition in Diabetes Management, with Dawn Noe, RDN, LD
|
Aug 23, 2023 |
|
Diabetes Dialogue: Implications of SELECT Trial and Brenzavvy on Cost Plus Drugs
|
Aug 23, 2023 |
|
Diabetes Dialogue: ADCES 2023 Recap
|
Aug 23, 2023 |
|
Diabetes Dialogue: ADA 2023 Recap
|
Aug 23, 2023 |
|
Diabetes Dialogue: Latest News in Insulin Delivery, with Gary Scheiner, MS
|
Aug 23, 2023 |
|
Diabetes Dialogue: Embracing Diabetes Tech and Social Media as a Clinician, with David Ahn, MD
|
Aug 23, 2023 |
|
Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric
|
Aug 23, 2023 |
|
Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO
|
Aug 23, 2023 |
|
Diabetes Dialogue: "Second-Generation" Obesity Medications, with W. Timothy Garvey, MD
|
Aug 23, 2023 |
|
Diabetes Dialogue: Improving Implementation of New Technology, with Cari Berget, RN, MPH
|
Aug 23, 2023 |
|
Diabetes Dialogue: Managing & Addressing Mental Health Needs in Diabetes
|
Aug 23, 2023 |
|
Diabetes Dialogue: Reforming Language in Metabolic Disease, with Jane Dickinson, RN, PhD
|
Aug 23, 2023 |
|
Diabetes Dialogue: Diabetic Foot Ulcers and Social Determinants of Health
|
Aug 23, 2023 |
|
Diabetes Dialogue: What to Know about the iLet Bionic Pancreas
|
May 26, 2023 |
|
Diabetes Dialogue: Breaking Down AACE's New Type 2 Diabetes Management Algorithms
|
May 18, 2023 |
|
Diabetes Dialogue: Breaking Down the Medtronic 780G Approval, with Robert Vigersky, MD
|
May 12, 2023 |
|
Diabetes Dialogue: SURMOUNT-2 Reaction, Omnipod GO, and Verapamil for T1D
|
May 03, 2023 |
|
Diabetes Dialogue: CMS Expansion Ushers in New Age of CGM Access
|
Mar 17, 2023 |
|
Diabetes Dialogue: ATTD 2023 Recap
|
Mar 03, 2023 |
|
Diabetes Dialogue: Practical Updates in Pediatric Diabetes, with Stuart Weinzimer, MD
|
Mar 02, 2023 |
|
Diabetes Dialogue: Technology Guidelines and Uptake in Diabetes, with Grazia Aleppo, MD
|
Mar 01, 2023 |
|
Diabetes Dialogue: The Role of Patient Voice in Diabetes Management
|
Feb 28, 2023 |
|
Diabetes Dialogue: Actualizing the Optimal Role of Inhaled Insulin, with Joanne Rinker, MS, RDN
|
Feb 28, 2023 |
|
Diabetes Dialogue: Updates in Diabetes Management from ATTD 23, with Irl Hirsch, MD
|
Feb 26, 2023 |
|
Diabetes Dialogue: Screenings for Hearing Loss in Diabetes, with Joanne Rinker, MS, RDN
|
Feb 25, 2023 |
|
Diabetes Dialogue: Mental Health and PRO Standardization, with Katharine Barnard-Kelly, PhD
|
Feb 25, 2023 |
|
Diabetes Dialogue: FDA Clearance of Tidepool Loop
|
Jan 30, 2023 |
|
Diabetes Dialogue: ADCES DTC 22, with Jennifer Okemah, RD, and Gary Scheiner, MS
|
Jan 21, 2023 |
|
Diabetes Dialogue: The Prospect of a Bionic Pancreas, with Steven Russell, MD, PhD
|
Jan 14, 2023 |
|
Diabetes Dialogue: December 2022
|
Dec 23, 2022 |
|
Diabetes Dialogue: The Psychology of Diabetes Management, with Jill Weissberg-Benchell, PhD
|
Dec 23, 2022 |
|
Diabetes Dialogue: Updates in Inpatient Management of Diabetes, with Jane Jeffrie Seley, DNP, MPH
|
Dec 13, 2022 |
|
Diabetes Dialogue: What Teplizumab Means for Type 1 Diabetes
|
Nov 17, 2022 |
|
Diabetes Dialogue: Obesity Updates, with Lydia Alexander, MD
|
Nov 14, 2022 |
|
Diabetes Dialogue: GLP-1 RA Shortage & ADA/KDIGO Recommendations
|
Oct 24, 2022 |
|
Diabetes Dialogue: EASD 2022 and Recent CGM News
|
Oct 13, 2022 |
|
Diabetes Dialogue: September 2022
|
Oct 03, 2022 |
|
Diabetes Dialogue: ADCES 2022 Recap
|
Aug 24, 2022 |
|
Diabetes Dialogue: Updates in Diabetes Management at ADCES, with Jennifer Clements, PharmD
|
Aug 17, 2022 |
|
Diabetes Dialogue: Sit Down with Diabetes Care and Education Specialist of the Year, Anastasia Albanese-O'Neill, PhD
|
Aug 15, 2022 |
|
Diabetes Dialogue: T1D Exchange, with David Walton
|
Aug 14, 2022 |
|
Diabetes Dialogue: Exploring DiabetesWise, with Korey Hood, PhD
|
Aug 14, 2022 |
|
Diabetes Dialogue: The Race to Cure T1D
|
Jul 29, 2022 |
|
Diabetes Dialogue: Prescribing Tirzepatide, Biosimilar Insulins, & Misdiagnosis of T1D
|
Jun 24, 2022 |
|
Diabetes Dialogue: Inside ADA 2022
|
Jun 10, 2022 |
|
Diabetes Dialogue: Inequities & Barriers in Diabetes, with Jasmine Gonzalvo, PharmD
|
Jun 09, 2022 |
|
Diabetes Dialogue: Frontline Perspective from ADA 2022, with Gary Scheiner, MS, CDE
|
Jun 09, 2022 |
|
Diabetes Dialogue: Optimizing CGM Uptake in Primary Care
|
Jun 07, 2022 |
|
Diabetes Dialogue: Tirzepatide in Action & AACE 2022 Recap
|
May 20, 2022 |
|
Diabetes Dialogue: ATTD 2022 Recap
|
May 06, 2022 |
|
Diabetes Dialogue: April 2022
|
Apr 28, 2022 |
|
Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives
|
Mar 30, 2022 |
|
Semaglutide 2.4 mg (Wegovy):A Turning Point for Obesity
|
Jun 25, 2021 |
|
Subcutaneous Semaglutide for Weight Loss with Thomas Wadden, PhD
|
Mar 16, 2021 |
|
Tirzepatide for Weight Loss and Lowering HbA1c with Juan Frias, MD
|
Mar 15, 2021 |
|
Dietary Interventions and the Role of Nutrition in Obesity with Ariana Chao, PhD, CRNP
|
Feb 17, 2021 |
|
Jeffrey Curtis, MD: Osteoporosis in 2020
|
Dec 07, 2020 |
|
Osilodrostat and Treatment of Cushing's Disease
|
Oct 30, 2020 |
|
Terri Lipman, PhD, CRNP: Addressing Racial Disparities in Medicine
|
Oct 29, 2020 |
|
Raymond Douglas, MD, PhD: State of Thyroid Eye Disease in 2020
|
Oct 19, 2020 |
|
Muthiah Vaduganathan, MD: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 RAs
|
Oct 08, 2020 |
|
Prof. Hiddo Heerspink: Insights from DAPA-CKD
|
Sep 01, 2020 |
|
Joshua Denson, MD: Metabolic Syndrome and COVID-19 Outcomes
|
Sep 01, 2020 |
|
Robert Busch, MD: Topline Results of EMPEROR-REDUCED
|
Jul 31, 2020 |
|
Diabetes Research & COVID-19
|
Jul 31, 2020 |